Biotech seed company Inari has secured a $103 million funding round to develop and commercialise higher-yielding seeds that demand fewer resources. This initiative plans to use AI-powered predictive ...
Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal dilution. Inari shareholders are getting a fair price relative to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results